http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114586769-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d224b14c9cb4f95b55a22b9824eb7d8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0221 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0226 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02 |
| filingDate | 2020-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0116092a612bc4f7e09d1f4113c67a24 |
| publicationDate | 2022-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-114586769-A |
| titleOfInvention | Serum-free cell cryopreservation solution for cell cryopreservation and cryopreservation method thereof |
| abstract | The present invention relates to a cell cryopreservation solution for cryopreserving immune cells and a cryopreservation method thereof, wherein the killer cells induced by cytokines are particularly preferred. The composition of the cell cryopreservation solution is serum-free and consists of the following components: (1) mixed basal medium, (2) dimethyl sulfoxide (DMSO), (3) serum substitute, (4) dextran (Dextran ). It is characterized in that the preservation solution is a mixed culture medium and a serum substitute to achieve the function of serum-free cryopreservation. It is used for immune cells, especially natural killer cells, which can maintain more than 80% of the cytotoxic function and functional cell markers after thawing, and have a high-concentration cell load. |
| priorityDate | 2020-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.